Search

everythinglearnresearchcommunity

for

Search:↓

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Activated platelet-rich plasma helps hair growth by boosting growth factors and cell growth pathways in hair cells.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Eastern Red Bat hair contains various glycerophospholipids, mainly phosphatidylcholine.

Iron deficiency might contribute to hair loss in women.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Adding L-glutamine to the diet of Hanwoo steers may boost their immune system and help them cope with heat.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The study aims to create a model to improve personalized and preventive health care.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.